Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Baricitinib significantly regrows hair in severe alopecia areata patients.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

A cluster of sulfur-rich hair protein genes was found on chromosome 17.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

The C-terminal tail of AHF/trichohyalin is essential for organizing keratin filaments in keratinocytes.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

A new gene mutation causes a rare type of hair loss.

Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Genetic analysis is crucial for diagnosing and managing cerebral arteriopathy.

A new AIRE gene mutation causes rare autoimmune symptoms in a Lebanese boy.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Astragaloside A may help fight lung cancer by targeting specific proteins.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Acne patients have higher skin mTORC1 activity, which is reduced by isotretinoin treatment.

Different parts of the body's fat tissue have unique cell types and characteristics, which could help treat chronic wounds.

Two gene areas linked to male pattern baldness found, more research needed.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.